vimarsana.com
Home
Live Updates
Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer : vimarsana.com
Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer
/PRNewswire/ -- Golgi Neurosciences S.r.l., the biotech incubator dedicated to the development of new treatments for devastating diseases, and Breye...
Related Keywords
Italy ,
Milan ,
Lombardia ,
Copenhagen ,
Køavn ,
Denmark ,
Danish ,
Ulrik Mouritzen ,
Chiara Liberati ,
Novo Holdings ,
Bioinnovation Institute ,
Danish Innovation Foundation Innovationsfonden ,
Danish Growth Foundation ,
Breye Therapeutics Aps ,
Related Macular Degeneration ,
Managing Director ,
Golgi Neurosciences ,
Scientific Advisory Board ,
Chief Executive Officer ,
Breye Therapeutics ,
Amyotrophic Lateral Sclerosis ,
Multiple Sclerosis ,
Diabetic Retinopathy ,
Age Related Macular Degeneration ,
Sound Bioventures ,
Danish Innovation Foundation ,
Golgi Neurosciences Breye Therapeutics ,
vimarsana.com © 2020. All Rights Reserved.